Articles
Register for OBGYN.net Editorial Advisor
Fibroid Resource Center & Discussion Forum
Phyllis J. Gee, MD, FACOG
North Texas Uterine Fibroid Institute
4601 Old Shepard Place, Suite 201
Plano, Texas 75093
Phone:
469-361-4000
Website: www.phyllisgeemd.com
Employment:
1/2004-pres
Phyllis J. Gee M.D.P.A. Plano, Texas Solo private practice Obstetrics & Gynecology
1995-2003
Willowbend Women’s Center P.A. Plano, Texas Group private practice Obstetrics & Gynecology
1988-1995
Phyllis J. Gee M.D.P.A. Plano, Texas Solo private practice Obstetrics & Gynecology
1986-1988
Cigna Healthplan of Texas Garland, Texas Attending Physician Staff-model HMO
Academic Appointments:
1984-1986
Columbia Presbyterian, Harlem Hospital Ctr. New York, New York Assistant Attending Physician
Post Graduate Training:
1981-1983
Albert Einstein College of Medicine Affil Hosp Bronx, New York Resident in Obstetrics & Gynecology
1983-1984
Administrative Chief Resident
1980-1981
Wayne State University School of Med Affil Hosp Detroit, Michigan Resident in Obstetrics & Gynecology
Medical Education:
1976-1980
Wayne State University School of Med Detroit, Michigan Doctor of Medicine
Undergraduate
1972-1976
Cornell University Ithaca, New York B.S. Nutrition
Certification
1987
American Board of Obstetricians & Gynecologists
Licensure
1986-pres
Texas
Memberships:
American College of Obstetrics and Gynecology Texas Medical Association
Dallas County Medical Society
Special Interests:
Reproductive Endocrinology & Menopausal Health; Wellness & Prevention; Nutrition & Weight Control; Uterine Fibroids; Adolescent Gynecology; Female Sexual Dysfunction; Premature Birth; Health Disparities; Operative Endoscopy & Pelvic Reconstructive Surgery
Publications:
“Putting the Reigns on Stress and Promoting Optimal Health”, Eclipse Magazine, August 2008
“Enhanced MR Guided Focused Ultrasound Surgery Demonstrates Improved
Efficacy and
Durability”, Obstetrics & Gynecology Supplement, Gee, PJ, 9(4):71S, 2007.
ACOG ACM Poster. Presented at ACOG Annual Clinical Meeting, San Diego, CA. May 8, 2007
“Prolonged Pregnancy”, Family Practice Recertification, Gee, P.J., Cohen, W.R., 5(10):29, 1983
Research:
“A Randomized Study to Evaluate the Effectiveness and Safety of ExAblate Surgery Compared with Myomectomy for the Enhancement of Fertility Following Treatment of Uterine Fibroids in Women Seeking Pregnancy.”
“A Double-blind Randomized Placebo-and-Active-Controlled Efficacy and Safety Study of the Effects of Bazedoxifene/Conjugated Estrogens Combinations on Endometrial Hyperplasia and Prevention of Osteoporosis in Postmenopausal Women.”
“A Phase III Open Label Two-Arm Parallel Design Randomized Multicenter Study Evaluating the Safety and Efficacy of 25mg and 50mg Doses of Proellex (CDB-4124) to Assess Recurrence of Symptoms in the Treatment of Premenopausal Women with Symptomatic Uterine Fibroids.”
“A Double-blind Randomized Placebo-Controlled Study Assessing the Safety and Efficacy of DVS SR for the Treatment of Vasomotor Symptoms Associated with Menopause.”
“A Randomized ,Double-blind Placebo-controlled Parallel-group Study Evaluating the Safety and Efficacy of Clindamycin/Butoconazole Vaginal Cream in the Treatment of Mixed Bacterial Vaginosis/Vulvovaginal Candidiasis Infections.”
“A Multi-center, Post-Approval Study to gather additional data to evaluate the safety and long term effectiveness of MR guided Focused Ultrasound Surgery in the treatment of uterine fibroids.”
“A Phase 2, Randomized, Double-blind, Placebo-controlled Trial of the Use of 4,4’-Dihydroxybenzophenone-2,4-Dinitrophenyl-hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL).”
“A Randomized, Placebo-Controlled Phase II Study of Multiple Intravaginally Administered, Dosing Regimens of 851B Gel for the Treatment of Cervical High Risk HPV Infection.”
“A Randomized, Double-blind, Placebo Controlled , Parallel Group, Multicenter Study to Evaluate Efficacy and Safety of 0.65g and 1.3g Oral Doses of XP12B-MR TID Administered During Menstruation for the Treatment of Menorrhagia.”
“A Phase IV, Open-label, Single arm, Non-randomized trial in adult patients with OAB to evaluate symptom specific effectiveness of Tolterodine ER 4mg in patients with symptoms of OAB in a primary care setting.”
“Multi-center, Double-blind, Randomized, Placebo-controlled study to evaluate the safety and efficacy of topically applied Alprostadil (prostaglandin E1) for the treatment of hysterectomized women with Female Sexual Arousal Disorder (FSAD).”
“Multi-center, Efficacy and Safety of 2 Low-Dose Regimens of Premarin Cream administered vaginally in postmenopausal women with atrophic vaginitis.”
“Multi-center, Double-blind, Randomized, Placebo-controlled study comparing 3 continuous oral Angeliq combinations and 17-B-Estradiol with placebo for a treatment period of 8 weeks on ambulatory and office cuff blood pressure in postmenopausal women with Stage 1 or Stage 2 essential hypertension.”
“Multi-center, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, 7-Cycle Duration, Phase 3 study of oral Estradiol Valerate/Dienogest tablets for the treatment of Dysfunctional Uterine Bleeding
Presentations:
“Innovations in the Treatment of Uterine Fibroids with Magnetic Resonance Guided Focused Ultrasound Surgery”. Presbyterian Hospital of Dallas OB/GYN Section Meeting Continuing Medical Education, Dallas, Texas, December 9, 2008.
“MR Guided Focused Ultrasound of Uterine Fibroids in African American Patients”. AAGL 36th Annual Global Congress of Minimally Invasive Gynecology. Wash, DC., November 17, 2007
“Management of Abnormal Uterine Bleeding”. Texas Nurse Practitioner’s 19th Annual Conference, Dallas, Texas, September 7, 2007
“Management of Abnormal Uterine Bleeding”. Texas Nurse Practitioner’s 19th Annual Conference, Dallas, Texas, September 7, 2007
Latest Developments in HPV Related Diseases and Cervical Cancer”. Presbyterian Hospital of Plano. Plano, Texas, January 11, 2007.
“Pregnancy Changes”. March of Dimes Prenatal Health Education Program Training. Dallas, Texas, December 16, 2006
“MR Guided Focused Ultrasound Report on Efficacy and Long Term Follow-up of Uterine Fibroid Treatment”. National Medical Association Annual 2006 Convention and Scientific Assembly. Dallas, Texas, August 6, 2006
“Health Disparities in Women’s Health”. An Evening with Maya Angelou for the Maya Angelou Research Center on Minority Health. Dallas, Texas, August 6, 2006.
“Reproductive Health”. A HEALTHY BET Women’s Health Forum: Remembering Our Health.
“Women’s Wellness & Health Prevention”. Alpha Kappa Alpha Sorority Health Seminar. Palo Alto, CA, January, 2006
Radio & TV:
“Good Morning Texas”. Dallas, Texas. Discussed Diagnosis and Treatment of Uterine Fibroids
“WUSA-TV Morning Show”. Washington, DC. Discussed Treatment of Uterine Fibroids with MR Guided Focused Ultrasound Surgery
“Insights”. Dallas, Texas. Discussed Treatment of Uterine Fibroids with MR Guided Focused Ultrasound Surgery
“Prematurity Awareness “. Discussed the diagnosis and health impact of prematurity and programs for prevention initiated by the March of Dimes. Dallas, Texas.
References:
Upon request
Revised - 07/2010
